Simon Geir Møller

Title: Simon Geir Møller: Innovator in Biomarkers for Parkinson's Disease

Introduction

Simon Geir Møller is a notable inventor based in Queens, NY. He has made significant contributions to the field of medical research, particularly in the identification of biomarkers for Parkinson's disease. With a total of two patents to his name, Møller's work is paving the way for advancements in diagnostic methods.

Latest Patents

Møller's latest patents focus on circulating serum cell-free DNA biomarkers and methods. These patents detail biomarkers and methods for identifying circulating serum-based cfDNA sequences. The cfDNA sequences, known as PDcRAs, can be utilized to differentiate patients suffering from Parkinson's disease from non-PD patients. This innovative approach has the potential to enhance early diagnosis and treatment options for individuals affected by this debilitating condition.

Career Highlights

Simon Geir Møller is affiliated with St. John's University, where he continues to engage in groundbreaking research. His work has garnered attention in the scientific community, contributing to the understanding of genetic markers associated with neurological disorders. Møller's dedication to advancing medical science is evident through his innovative research and patent filings.

Collaborations

Møller collaborates with Ketan Patil, a fellow researcher, to further explore the implications of their findings in the field of biomarkers. Their partnership exemplifies the importance of teamwork in scientific research and innovation.

Conclusion

In summary, Simon Geir Møller is a distinguished inventor whose work on biomarkers for Parkinson's disease is making a significant impact in the medical field. His contributions are essential for the future of diagnostic methods and patient care.